Hyundai Pharmaceutical Co (XKRX:004310) EV-to-Revenue : 0.68 (As of May. 27, 2024)

Hyundai Pharmaceutical Co EV-to-Revenue Chart

Hyundai Pharmaceutical Co Annual Data
	Trend	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23
EV-to-Revenue		Get a 7-Day Free Trial					1.13	1.39	1.04	0.85	0.70

Hyundai Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-Revenue	Get a 7-Day Free Trial															0.85	0.83	0.72	0.70	0.69

Competitive Comparison of Hyundai Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Hyundai Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyundai Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hyundai Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hyundai Pharmaceutical Co's EV-to-Revenue falls into.

Hyundai Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hyundai Pharmaceutical Co's EV-to-Revenue for today is calculated as:

Hyundai Pharmaceutical Co's current Enterprise Value is ₩124,813 Mil.
Hyundai Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩184,640 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyundai Pharmaceutical Co  (XKRX:004310) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hyundai Pharmaceutical Co's PS Ratiofor today is calculated as:

Hyundai Pharmaceutical Co's share price for today is ₩3735.00.
Hyundai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,923.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyundai Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Pharmaceutical Co (XKRX:004310) Business Description